Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.

Bone Marrow Transplant

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA.

Published: November 2023

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622310	PMC
http://dx.doi.org/10.1038/s41409-023-02034-z	DOI Listing

Publication Analysis

abatacept prevention

prevention graft

graft versus

versus host

host disease

disease pediatric

pediatric patients

patients receiving

receiving 7/8

7/8 hla-mismatched

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!